KR20010041522A - 항-궤양의 질산염 약제 - Google Patents
항-궤양의 질산염 약제 Download PDFInfo
- Publication number
- KR20010041522A KR20010041522A KR1020007009693A KR20007009693A KR20010041522A KR 20010041522 A KR20010041522 A KR 20010041522A KR 1020007009693 A KR1020007009693 A KR 1020007009693A KR 20007009693 A KR20007009693 A KR 20007009693A KR 20010041522 A KR20010041522 A KR 20010041522A
- Authority
- KR
- South Korea
- Prior art keywords
- salts
- nitrate
- och
- residues
- free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI000442A IT1299198B1 (it) | 1998-03-05 | 1998-03-05 | Sali nitrati di farmaci antiulcera |
| ITMI98A000442 | 1998-03-05 | ||
| PCT/EP1999/001226 WO1999045004A1 (en) | 1998-03-05 | 1999-02-25 | Nitrate salt of anti-ulcer medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010041522A true KR20010041522A (ko) | 2001-05-25 |
Family
ID=11379185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007009693A Abandoned KR20010041522A (ko) | 1998-03-05 | 1999-02-25 | 항-궤양의 질산염 약제 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6503929B1 (enExample) |
| EP (1) | EP1068196B1 (enExample) |
| JP (1) | JP2002505328A (enExample) |
| KR (1) | KR20010041522A (enExample) |
| CN (1) | CN1249053C (enExample) |
| AT (1) | ATE273297T1 (enExample) |
| AU (1) | AU752919B2 (enExample) |
| BR (1) | BR9908428A (enExample) |
| CA (1) | CA2322493A1 (enExample) |
| DE (1) | DE69919341T2 (enExample) |
| DK (1) | DK1068196T3 (enExample) |
| ES (1) | ES2226357T3 (enExample) |
| HU (1) | HUP0100853A3 (enExample) |
| IL (1) | IL137721A0 (enExample) |
| IT (1) | IT1299198B1 (enExample) |
| PT (1) | PT1068196E (enExample) |
| RU (1) | RU2228331C2 (enExample) |
| SI (1) | SI1068196T1 (enExample) |
| WO (1) | WO1999045004A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| WO2000028988A1 (en) | 1998-11-17 | 2000-05-25 | Nitromed, Inc. | Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| CN100486573C (zh) | 1999-12-23 | 2009-05-13 | 硝化医药股份有限公司 | 硝基化的和亚硝基化的环加氧酶-2抑制剂、组合物及其用途 |
| IT1317735B1 (it) * | 2000-01-26 | 2003-07-15 | Nicox Sa | Sali di agenti antimicrobici. |
| SE0002476D0 (sv) | 2000-06-30 | 2000-06-30 | Astrazeneca Ab | New compounds |
| ATE338544T1 (de) | 2000-12-21 | 2006-09-15 | Nitromed Inc | Substituierte arylverbindungen als neue, cyclooxygenase-2-selektive inhibitoren, zusammensetzungen und verwendungsverfahren |
| GB2393189B (en) * | 2001-07-19 | 2005-06-15 | Trikon Holdings Ltd | Depositing a tantalum film |
| US7220749B2 (en) | 2002-06-11 | 2007-05-22 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| US7211598B2 (en) | 2002-06-28 | 2007-05-01 | Nitromed, Inc. | Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| CA2491127A1 (en) | 2002-07-03 | 2004-01-15 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| CA2493156A1 (en) | 2002-07-29 | 2004-02-05 | Nitromed, Inc. | Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| CA2493618A1 (en) * | 2002-08-01 | 2004-02-12 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| RU2304967C2 (ru) * | 2005-05-26 | 2007-08-27 | Государственное общеобразовательное учреждение высшего профессионального образования Казанский государственный медицинский университет | Способ лечения язвенной болезни желудка и двенадцатиперстной кишки |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1397436A (en) * | 1972-09-05 | 1975-06-11 | Smith Kline French Lab | Heterocyclic n-cyanoguinidines |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4375547A (en) | 1980-10-02 | 1983-03-01 | Eli Lilly And Company | N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine |
| EP0224612A1 (de) * | 1985-12-05 | 1987-06-10 | HEUMANN PHARMA GMBH & CO | Verfahren zur Herstellung von N-Cyano-N'-methyl-N"[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidin |
| ATE86619T1 (de) * | 1987-04-06 | 1993-03-15 | Heumann Pharma Gmbh & Co | Verfahren zur herstellung von nitroethenderivaten. |
| TW205041B (enExample) * | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co |
-
1998
- 1998-03-05 IT IT98MI000442A patent/IT1299198B1/it active IP Right Grant
-
1999
- 1999-02-25 US US09/622,068 patent/US6503929B1/en not_active Expired - Fee Related
- 1999-02-25 CA CA002322493A patent/CA2322493A1/en not_active Abandoned
- 1999-02-25 SI SI9930655T patent/SI1068196T1/xx unknown
- 1999-02-25 AU AU30303/99A patent/AU752919B2/en not_active Ceased
- 1999-02-25 DE DE69919341T patent/DE69919341T2/de not_active Expired - Fee Related
- 1999-02-25 IL IL13772199A patent/IL137721A0/xx unknown
- 1999-02-25 EP EP99911708A patent/EP1068196B1/en not_active Expired - Lifetime
- 1999-02-25 JP JP2000534547A patent/JP2002505328A/ja not_active Withdrawn
- 1999-02-25 ES ES99911708T patent/ES2226357T3/es not_active Expired - Lifetime
- 1999-02-25 BR BR9908428-7A patent/BR9908428A/pt not_active Application Discontinuation
- 1999-02-25 WO PCT/EP1999/001226 patent/WO1999045004A1/en not_active Ceased
- 1999-02-25 PT PT99911708T patent/PT1068196E/pt unknown
- 1999-02-25 HU HU0100853A patent/HUP0100853A3/hu unknown
- 1999-02-25 AT AT99911708T patent/ATE273297T1/de not_active IP Right Cessation
- 1999-02-25 KR KR1020007009693A patent/KR20010041522A/ko not_active Abandoned
- 1999-02-25 CN CNB998035343A patent/CN1249053C/zh not_active Expired - Fee Related
- 1999-02-25 DK DK99911708T patent/DK1068196T3/da active
- 1999-02-25 RU RU2000122968/04A patent/RU2228331C2/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI980442A1 (it) | 1999-09-05 |
| DK1068196T3 (da) | 2004-11-29 |
| PT1068196E (pt) | 2004-10-29 |
| ES2226357T3 (es) | 2005-03-16 |
| WO1999045004A1 (en) | 1999-09-10 |
| US6503929B1 (en) | 2003-01-07 |
| DE69919341D1 (de) | 2004-09-16 |
| IL137721A0 (en) | 2001-10-31 |
| IT1299198B1 (it) | 2000-02-29 |
| EP1068196A1 (en) | 2001-01-17 |
| HUP0100853A3 (en) | 2003-01-28 |
| DE69919341T2 (de) | 2005-09-08 |
| JP2002505328A (ja) | 2002-02-19 |
| HUP0100853A2 (hu) | 2001-10-28 |
| AU3030399A (en) | 1999-09-20 |
| EP1068196B1 (en) | 2004-08-11 |
| CA2322493A1 (en) | 1999-09-10 |
| AU752919B2 (en) | 2002-10-03 |
| CN1249053C (zh) | 2006-04-05 |
| BR9908428A (pt) | 2000-10-31 |
| RU2228331C2 (ru) | 2004-05-10 |
| SI1068196T1 (en) | 2004-12-31 |
| ATE273297T1 (de) | 2004-08-15 |
| CN1291982A (zh) | 2001-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20010041522A (ko) | 항-궤양의 질산염 약제 | |
| RU96101139A (ru) | Новые производные эритромицина, способ их получения и применение в качестве лекарственных средств | |
| JPH0912560A (ja) | 改良された抗ウイルス化合物 | |
| KR100579810B1 (ko) | 궤양용 약학 조성물 | |
| JPS6229566A (ja) | 新規グアニジノメチル安息香酸誘導体 | |
| JP2002505328A5 (enExample) | ||
| JP2764262B2 (ja) | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 | |
| JPH0333127B2 (enExample) | ||
| DE2638067C2 (de) | Penicilline und Verfahren zu deren Herstellung | |
| JPS6243987B2 (enExample) | ||
| AU2005243793A1 (en) | Stable pharmaceutical composition containing benzimidazole derivatives and method of manufacturing the same | |
| GB2200353A (en) | Rifamycin derivative salts | |
| JPS6330462A (ja) | 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤 | |
| KR0144442B1 (ko) | 수용성 비스무스 화합물 및 그의 제조 방법 | |
| JPH072636B2 (ja) | 胃腸の細胞保護剤 | |
| JPS59216875A (ja) | 新規ｎ−シアノ−ホルムアミジン、その製法及びこれを含有するヒスタミンｈ↓２−レセプタ−「きつ」抗剤 | |
| JPS5885895A (ja) | セフアロスポリン誘導体および経口投与用細菌感染症治療剤 | |
| JPH06256185A (ja) | ビタミンｅ誘導体およびそれを有効成分とする抗潰瘍剤 | |
| KR19980035382A (ko) | 신규한 비페닐 디카르복실산 유도체와 이의 제조방법 | |
| JPS62148486A (ja) | チアゾ−ル誘導体およびその製造法 | |
| HU187300B (en) | Process for preparing 5-sulphamoyl-ortanilic and derivatives and pharmaceutical compositons containing such compounds as activa substanes | |
| JPH06184153A (ja) | 新規なフェノチアジン化合物及びその塩、それらの製法並びにそれらを有効成分とする消化性潰瘍治療剤 | |
| KR20000016484A (ko) | 신규 화합물 | |
| JPS632433B2 (enExample) | ||
| CH655715A5 (fr) | Derives amines de l'acide 4-phenyl 4-oxo 2-butenoique, leur preparation et medicaments les renfermant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20000901 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20040217 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20051111 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20060309 |
|
| NORF | Unpaid initial registration fee | ||
| PC1904 | Unpaid initial registration fee |